About
Bioventus is a global leader of active orthopaedic healing, providing clinically proven and cost-effective therapies and diagnostics that help patients regain active lifestyles. Bioventus' products are known for their innovation, safety and effectiveness. The company is the recognized leader in bone stimulation devices and among the leading distributors of osteoarthritis joint fluid therapies. Key products include: - EXOGEN(r) Ultrasound Bone Healing System - SUPARTZ(r) Joint Fluid Therapy (US only) - DUROLANE(r) Hyaluronic Acid, Single Injection (Outside US only) Bioventus' adherence to high quality standards, commitment to evidence-based medicine and strong ethical behavior makes the company a trusted partner for thousands of physicians worldwide. Bioventus employs 500 people and generates about $240 million in yearly revenue. The company is headquartered in Durham, N.C. Prior to launch in 2012, Bioventus was operating as the Biologics Division of Smith &
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 115 investors are based in Durham, North Carolina, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Durham, US
Contact Information
Find more investors like Bioventus
Search Investors